1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
4.1. Product Pipeline
5. MEXICO RUO IMMUNOASSAY MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Immunoassay Kits
5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits
5.2.1.1. Conventional
5.2.1.2. Manual
5.2.2. Radioimmunoassay (RIA Kits)
5.2.2.1. Conventional
5.2.2.2. Manual
5.2.3. Chemiluminescent Immunoassay (CLIA) Kits
5.3. Immunoassay Reagents
5.4. Microplate Reader
5.5. Microplates
5.6. Analyzers
5.6.1. Automated Analyzers
5.6.2. Non-Automated Analyzers
5.7. Microplate Washers
5.8. Others
6. MEXICO RUO IMMUNOASSAY MARKET BY SAMPLE TYPE
6.1. Introduction
6.2. Plasma
6.3. Blood Serum
6.4. Urine
6.5. Saliva
6.6. Cell or Tissue Culture Medium
6.7. Others
7. MEXICO RUO IMMUNOASSAY MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Blood Screening and Toxicology
7.4. Infectious Disease
7.5. Cardiology
7.6. Allergy Diagnostic
7.7. Rare and Emerging Condition Diagnostic
7.8. Others
8. MEXICO RUO IMMUNOASSAY MARKET BY END-USER
8.1. Introduction
8.2. Research and Academic Laboratories
8.3. Pharmaceutical and Biotechnology Companies
9. MEXICO RUO IMMUNOASSAY MARKET BY STATE
9.1. Introduction
9.2. Mexico City
9.2.1. By Technology
9.2.2. By Sample Type
9.2.3. By Application
9.2.4. By End-User
9.3. Jalisco
9.3.1. By Technology
9.3.2. By Sample Type
9.3.3. By Application
9.3.4. By End-User
9.4. Nuevo Leon
9.4.1. By Technology
9.4.2. By Sample Type
9.4.3. By Application
9.4.4. By End-User
9.5. Baja California
9.5.1. By Technology
9.5.2. By Sample Type
9.5.3. By Application
9.5.4. By End-User
9.6. Guerrero
9.6.1. By Technology
9.6.2. By Sample Type
9.6.3. By Application
9.6.4. By End-User
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. DIAsource Immunoassay SA
11.2. Danaher (Beckman Coulter, Inc.)
11.3. PerkinElmer, Inc
11.4. Siemens Healthineers
11.5. F.Hoffmann-La Roche Ltd.
11.6. Abott Laboratories
11.7. Thermo Fisher Scientific, Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations LIST OF FIGURESLIST OF TABLES